Oxidative stress in kidney disease patients;Oxidační stres u pacientů s onemocněním ledvin

Vnitrni Lekarstvi

Volumn 58, Issue 3, 2012, Pages 202-207

  Vostalova J ^a   Galandáková, Adéla ^a   Strebl P ^a   Zadrazil J ^a   Kajabova M ^b   Schneiderka, P ^b  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b Oddeleni Klinicke Biochemie   (Czech Republic)

Author keywords

Antioxidants; Dialysis; Immunosuppressives; Kidney; Reactive oxygen and nitrogen species; Transplantation

Indexed keywords

ANTIOXIDANT; BIOLOGICAL MARKER; REACTIVE OXYGEN METABOLITE;

CHRONIC KIDNEY DISEASE; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; OXIDATIVE STRESS; REVIEW; URINARY EXCRETION;

ANTIOXIDANTS; CARDIOVASCULAR DISEASES; FREE RADICALS; HUMANS; KIDNEY FAILURE, CHRONIC; LIPID PEROXIDATION; OXIDATIVE STRESS;

EID: 84859764440     PISSN: 0042773X     EISSN: 18017592     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Levey AS, Beto JA, Coronado BE et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis 1998; 32: 853-906. (Pubitemid 28516321)
2. Dusilová Sulková S. Klinický význam cévního postižení u diabetiků s onemocněním ledvin - pohled neurologa. Vnitr - Lék 2010; 56: 351-355.
3. Zemánek D. Ischemická choroba srdeční a onemocnění ledvin. Kardiol Rev 2005; 4: 191-194.
4. Yeo FE, Villines TC, Bucci JR et al. Cardiovascular risk in stage 4 and 5 nephropathy. Adv Chronic Kidney Dis 2004; 11: 116-133. (Pubitemid 39295207)
5. Rucker D, Tonelli M. Cardiovascular risk and management in chronic kidney disease. Nat Rev Nephrol 2009; 5: 287-296.
6. Himmelfarb J. Relevance of oxidative pathways in the pathophysiology of chronic kidney disease. Cardiol Clin 2005; 23: 319-330. (Pubitemid 41097354)
7. Gutteridge JM. Lipid peroxidation and anti-oxidants as biomarkers of tissue damage. Clin Chem 1995; 41: 1819-1828.
8. Babior BM. Superoxide: a two-edged sword. Braz J Med Biol Res 1997; 30: 141-155. (Pubitemid 127518238)
9. Darley-Usmar V, Halliwell B. Blood radicals: reactive nitrogen species, reactive oxygen species, transition metal ions, and the vascular system. Pharm Res 1996; 13: 649-662. (Pubitemid 26156215)
10. Racek J. Oxidační stres a možnosti jeho ovlivnění. Praha: Galén 2003.
11. DeLeo FR, Renee J, McCormick S et al. Neutrophils exposed to bacterial lipopolysaccharide upregulate NADPH oxidase assembly. J Clin Incest 1998; 101: 455-463. (Pubitemid 28067343)
12. Himmelfarb J. Uremic toxicity, oxidative stress, and hemodialysis as renal replacement therapy. Semin Dial 2009; 22: 636-643.
13. Kim HJ, Vaziri ND. Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure. AmJ Physiol Renal Physiol 2010; 298: F662-F671.
14. Sies H. Oxidative stress: oxidants and anti-oxidants. Exp Physiol 1997; 82: 291-295.
15. Alhamdani MS, Al-Kassir AH, Jateel NA et al. Elevated levels of alkanals, alkenals and 4-HO-alkenals in plasma of hemodialysis patients. Am J Nephrol 2006; 26: 299-303.
16. Morena M, Delbosc S, Dupuy AM et al. Overproduction of reactive oxygen species in end-stage renal disease patients: a potential component of hemodialysis-associated inflammation. Hemodial Int 2005; 9: 37-46. (Pubitemid 40932774)
17. Steinberg D, Parthasarathy S, Carew TE et al. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915-924. (Pubitemid 19101597)
18. Locatelli F, Canaud B, Eckardt KU et al. Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant 2003; 18: 1272-1280. (Pubitemid 36826946)
19. Zadák Z, Hyspler R, Tichá A et al. Antioxidants and vitamins in clinical conditions. Physiol Res 2009; 58: S13-S17.
20. Štípek S et al. Antioxidanty a volné radikály ve zdraví a v nemoci. Praha: Grada 2000.
21. Kalousová M, Zima T, Tesař V et al. Advanced glycoxidation end products in chronic diseases - clinical chemistry and genetic background. Mutat Res 2005; 579: 37-46. (Pubitemid 41540131)
22. Descamps-Latscha B, Witko-Sarsat V. Oxidative stress in chronic renal failure and hemodialysis. Nephrologie 2003; 24: 377-379. (Pubitemid 37484283)
23. Capeillere-Blandin C, Deleveau T, Descamps-Latscha B. Structural modification of human β2-microglobulin treated with oxygen-derived radicals. Biochem J 1991; 277: 175-182.
24. Mitrogianni Z, Barbouti A, Galaris D et al. Oxidative modification of albumin in predialysis, hemodialysis, and peritoneal dialysis patients. Nephron Clin Pract 2009; 113: 234-240.
25. Simmons EM, Langone A, Sezer MT et al. Effect of renal transplantation on biomarkers of inflammation and oxidative stress in end-stage renal disease patients. Transplantation 2005; 79: 914-919. (Pubitemid 40586863)
26. Pupim LB, Himmelfarb J, McMonagle E et al. Influence of initiation of maintenance hemodialysis on biomarkers of inflammation and oxidative stress. Kidney Int 2004; 65: 2371 -2379.
27. Marsche G, Frank S, Hrzenjak A et al. Plasma-advanced oxidation protein products are potent high-density lipoprotein receptor antagonists in vivo. Circ Res 2009; 104: 750-757.
28. Bertram C, Hass R. Cellular responses to reactive oxygen species-induced DNA damage and aging. Biol Chem 2008; 389: 211-220. (Pubitemid 351329029)
29. Klaunig JE, Kamendulis LM, Hocevar BA. Oxidative stress and oxidative damage in carcinogenesis. Toxicol Pathol 2010; 38: 96-109.
30. Valko M, Izakovic M, Mazur M et al. Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem 2004; 266: 37-56. (Pubitemid 39562306)
31. Herman M, Ori Y, Chagnac A et al. Spontaneous DNA repair increases during hemodialysis. Nephron Clin Pract 2008; 108: c188-c193. (Pubitemid 351588111)
32. Horoz M, Bolukbas FF, Bolukbas C et al. The association of circulating leptin level with peripheral DNA damage in hemodialysis subjects. Clin Biochem 2006; 39: 918-922. (Pubitemid 44344688)
33. Kobras K, Schupp N, Nehrlich K et al. Relation between different treatment modalities and genomic damage of end-stage renal failure patients. Kidney Blood Press Res 2006; 29: 10-17. (Pubitemid 43875167)
34. Stoyanova E, Sandoval SB, Zúñiga LA et al. Oxidative DNA damage in chronic renal failure patients. Nephrol Dial Transplant 2010; 25: 879-885.
35. Racek J, Holeček V. Enzymy a volné radikály. Chem listy 1999; 93: 774-780.
36. Matés JM, Pérez-Gómez C, Núñez de Castro I. Antioxidant enzymes and human diseases. Clin Biochem 1999; 32: 595-603.
37. Tsuchikura S, Shoji T, Shimomura N et al. Serum C-reactive protein and thioredoxin levels in subjects with mildly reduced glomerular filtration rate. BMC Nephrol 2010; 11: 7-13.
38. Kand'ár R, Záková P. Allantoin as a marker of oxidative stress in human erythrocytes. Clin Chem Lab Med 2008; 46: 1270-1274.
39. Kohen R, Nyska A. Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol 2002; 30: 620-650. (Pubitemid 36018731)
40. Sánchez-Lozada LG, Nakagawa T, Kang DH et al. Hormonal and cytokine effects of uric acid. Curr Opin Nephrol Hypertens 2006; 15: 30-33.
41. Lippi G, Montagnana M, Franchini M et al. The paradoxical relationship between serum uric acid and cardiovascular disease. Clin Chim Acta 2008; 392: 1-7.
42. Puchades Montesa MJ, González Rico MA, Solís Salguero MA et al. Study of oxidative stress in advanced kidney disease. Nefrologia 2009; 29: 464-473.
43. Romeu M, Nogues R, Marcas L et al. Evaluation of oxidative stress biomarkers in patients with chronic renal failure: a case control study. BMC Res Notes 2010; 3: 20-26.
44. Siu YP, Leung KT, Tong MK et al. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. AmJ Kidney Dis 2006; 47: 51-59. (Pubitemid 41828266)
45. Alhamdani MS. Impairment of glutathione biosynthetic pathway in uraemia and dialysis. Nephrol Dial Transplant 2005; 20: 124-128.
46. Armstrong D. Advanced Protocols in Oxidative Stress I. New York: Springer 2008.
47. Armstrong D. Advanced Protocols in Oxidative Stress II. New York: Springer 2010.
48. Cao G, Prior RL. Comparison of different analytical methods for assessing total antioxidant capacity of human serum. Clin Chem 1998; 44: 1309-1315. (Pubitemid 28283072)
49. Wayner DD, Burton GW, Ingold KU et al. Quantitative measurement of the total, peroxyl radical-trapping antioxidant capability of human blood plasma by controlled peroxidation. The important contribution made by plasma proteins. FEBS Lett 1985; 187: 33-37. (Pubitemid 15250011)
50. Kuchta A, Pacanis A, Kortas-Stempak B et al. Estimation of Oxidative Stress Markers in Chronic Kidney Disease. Kidney Blood Press Res 2010; 34: 12-19.